Stay updated on Venetoclax Combo vs Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.

Latest updates to the Venetoclax Combo vs Azacitidine in AML Clinical Trial page
- ChecktodayChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous v3.3.3. This appears to be a minor system update with no changes to study information.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study locations were updated, with many new sites added across multiple countries and numerous previously listed locations removed.SummaryDifference3%

- Check35 days agoChange DetectedA new PubMed citation by Venditti et al. was added to the Publications From PubMed section. The prior 'Online ahead of print' listing for the same article was removed.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded a note that PubMed-derived publications are automatically populated and may not relate to the study, and updated the revision tag to v3.3.2.SummaryDifference0.0%

- Check57 days agoChange DetectedThe government funding status notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedThe screenshots show only minor formatting changes with no alteration to core study details such as the title, NCT number, sponsor, enrollment, locations, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Venetoclax Combo vs Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.